Pancreatic Cancer
Description
Pancreatic cancer shows among the highest mortality rates of any cancer, with a 5-year relative survival rate of less than 5%. By the time of initial diagnosis, metastatic disease is commonly present. Established risk factors include a family history of pancreatic cancer, a medical history of diabetes type 2, and cigarette smoking (summary by Amundadottir et al., 2009).
Clinical Features
Top most frequent phenotypes and symptoms related to Pancreatic Cancer
- Ataxia
- Neoplasm
- Pain
- Fatigue
- Diabetes mellitus
- Abdominal pain
- Weight loss
- Jaundice
- Carcinoma
- Telangiectasia
And another 10 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available PANCREATIC CANCER have a estimated prevalence of 3.5 per 100k in Europe.— No data available about the known clinical features onset.
Alternative names
Pancreatic Cancer Is also known as pancreatic carcinoma, pancreatic acinar carcinoma.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Pancreatic Cancer Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53
Specificity
100 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53
Specificity
100 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53
Specificity
100 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53
Specificity
100 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
25 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
29 %
Genes
50 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
25 % |
You can get up to 823 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TRIGONOCEPHALY 1; TRIGNO1 SYSTEMIC MASTOCYTOSIS WITH AN ASSOCIATED CLONAL HEMATOLOGIC NON-MAST CELL LINEAGE DISEASE HYDROLETHALUS SYNDROME 2; HLS2 IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH STUVE-WIEDEMANN SYNDROME CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA